Chondrogenic Differentiation Medium Using Marine Polysaccharides
Solution Overview
Problem
Current methods for inducing chondrogenic differentiation in stem cells are not effective in producing stable chondrocytes, limiting the regeneration of functional cartilage for repairing damaged joints.
Innovation Solution
A chondrogenic differentiation medium is developed that includes transforming growth factors β and bone morphogenetic proteins, combined with low-molecular-weight sulfated polysaccharides derived from marine native exopolysaccharides, which are depolymerized and sulfated to enhance chondrogenic differentiation properties.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional chondrogenic differentiation media are used, then basic differentiation can occur, but stable chondrocyte production is not achieved
Solution Approach 1:
The patent combines growth factors (TGF-β, BMPs) with low-molecular-weight sulfated polysaccharides derived from marine exopolysaccharides to create a composite differentiation medium. This composite approach synergistically enhances both the stability and productivity of chondrogenic differentiation, overcoming the limitations of conventional single-component media.
Solution Approach 2:
The patent modifies the chemical parameters of the differentiation medium by introducing sulfated polysaccharides with specific molecular weights and sulfate degrees of substitution. These parameter changes optimize the medium's ability to induce stable chondrogenic differentiation while maintaining high productivity.
2Stability of the object's composition
If high-molecular-weight marine exopolysaccharides are used, then basic chondrogenic properties are maintained, but differentiation efficacy is limited
Solution Approach 1:
The patent segments the high-molecular-weight marine exopolysaccharides into low-molecular-weight fractions through controlled depolymerization. This segmentation increases the surface area and bioavailability of active sites, thereby enhancing chondrogenic differentiation efficiency while preserving the essential chondrogenic properties.
Solution Approach 2:
The patent changes the molecular weight parameter of the exopolysaccharides from high to low through chemical or enzymatic depolymerization. This parameter modification optimizes the polysaccharides' ability to interact with growth factors and cell surfaces, significantly improving differentiation efficiency.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The medium significantly increases chondrogenic differentiation, as evidenced by increased pellet volume, GAG production, and expression of chondrogenic markers, potentially leading to improved cartilage tissue formation for therapeutic applications.
Implementation Method 1
a step consisting of free-radical depolymerization of said native EPS so as to obtain a depolymerized EPS having a molecular weight of 5,000 to 100,000 g/mol
Implementation Method 2
a subsequent step consisting of sulfation of the depolymerized EPS, comprising adding to the depolymerized EPS at least one sulfation agent in an amount sufficient to obtain a sulfated polysaccharide having a degree of sulfate-group substitution of between 10% and 45% by weight
Data Source
Figure 1~2D
Figure 3
Figure 4
AI summary
The invention provides chondrogenic differentiation media comprising chondrogenic growth factors and low-molecular-weight sulfated polysaccharide derivatives of marine native exopolysaccharides (EPS) excreted by mesophilic marine bacteria from deep-sea hydrothermal environments. The invention relates to methods for inducing chondrogenic differentiation in pluripotent or multipotent cells, to cartilage tissues obtained by such methods, and to the use of such cartilage tissues for therapeutic purposes.